Science 37 Holdings, Inc.

The momentum for this stock is not very good. Tradey thinks it is not wise to invest in Science 37 Holdings, Inc..
Log in to see more information.

News

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC
Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

Globe Newswire 19,000-square-foot facility reflects the company's recent growth and continued commitment to the regionMORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient...\n more…

Science 37 Enrolls 42% of Trial Cohort in 8 Weeks
Science 37 Enrolls 42% of Trial Cohort in 8 Weeks

Globe Newswire Science 37 Supports Phase 3 Clinical Trial with Recruitment and Enrollment, Enhancing Access for Immunocompromised Patients Across the U.S.MORRISVILLE, N.C., July 18, 2024 (GLOBE NEWSWIRE...\n more…

Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials
Science 37 Quickly Impacts Performance in Under-Enrolling Clinical Trials

Globe Newswire Nearly 20 studies have successfully leveraged Science 37's medical and operational expertise to boost patient recruitment and enrollment activitiesRESEARCH TRIANGLE PARK, N.C., June 27, 2024 (GLOBE...\n more…

CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

Globe Newswire Science 37 Enrolls 21% of Study Participants at 11x the Speed of Traditional Research Sites Through its Virtual Site and Patient Recruitment SolutionsRESEARCH TRIANGLE PARK, N.C., June 12, 2024...\n more…

Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial
Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial

Globe Newswire Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial...\n more…

Science 37 Metasite Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance
Science 37 Metasite Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance

Globe Newswire Science 37's Virtual Site Model for Clinical Research Impresses in First-of-its-Kind FDA InspectionRESEARCH TRIANGLE PARK, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. today...\n more…